Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy.

ABSTRACT: Left ventricular hypertrophy (LVH) is an independent risk factor for adverse cardiovascular events and is often present in patients with hypertension. Treatment to reduce blood pressure and regress LVH is key to improving health outcomes, but currently available drugs have only modest cardioprotective effects. Improved understanding of the molecular mechanisms involved in the development of LVH may lead to new therapeutic targets in the future. There is now compelling evidence that the transcription factor Kruppel-like factor 15 (KLF15) is an important negative regulator of cardiac hypertrophy in both experimental models and in man. Studies have reported that loss or suppression of KLF15 contributes to LVH, through lack of inhibition of pro-hypertrophic transcription factors and stimulatio

SUBMITTER: Patel SK 

PROVIDER: S-EPMC5983718 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature